newsfilter
← Latest News
GlobeNewswire·

Amryt to Report Q3 2022 Results on November 3, 2022

Amryt to Report Q3 2022 Results on November 3, 2022 DUBLIN, Ireland, and Boston MA, October 19, 2022, Amryt (NASDAQ:AMYT) a global, commercial-stage biopharmaceutical company dedicated to acquiring, developing and